Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
DNTH | Dianthus Therapeutics, Inc. /DE/ | Title: Chief Financial and Operating Officer | $207 K | Nov 30, 2022 | ||
VRDN | Viridian Therapeutics, Inc.\DE | President and CEO, Director | Oct 30, 2023 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|